tiprankstipranks
Bionoid Pharma (BINP)
OTHER OTC:BINP
US Market

Bionoid Pharma (BINP) Financial Statements

3 Followers

Bionoid Pharma Financial Overview

Bionoid Pharma's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -2,210.00; Bionoid Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 11Dec 10Sep 10Jun 10Mar 10
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -98.14K$ -48.00K$ -71.86K$ -66.35K$ -66.24K
EBIT$ -5.67M$ -1.87M$ -834.55K$ -695.61K$ -482.80K
EBITDA$ -5.66M$ -1.86M$ -826.36K$ -687.28K$ -473.71K
Net Income Common Stockholders$ -5.68M$ -1.88M$ -839.39K$ -700.39K$ -491.36K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 300.38K$ 983.29K$ 90.27K$ 103.96K$ 12.45K
Total Assets$ 646.68K$ 1.33M$ 422.94K$ 437.88K$ 340.64K
Total Debt$ 34.61K$ 219.58K$ 215.54K$ 337.97K$ 341.93K
Net Debt$ -265.77K$ -763.71K$ 125.27K$ 234.01K$ 329.49K
Total Liabilities$ 2.13M$ 2.20M$ 2.07M$ 2.12M$ 2.08M
Stockholders Equity$ -1.48M$ -870.90K$ -1.65M$ -1.68M$ -1.74M
Cash Flow-
Free Cash Flow$ -665.24K$ -649.04K$ -389.36K$ -443.32K$ -263.25K
Operating Cash Flow$ -665.02K$ -645.16K$ -389.26K$ -440.24K$ -259.63K
Investing Cash Flow$ -218.00$ -3.89K$ -99.00$ -3.07K$ -3.62K
Financing Cash Flow$ -20.00K$ 1.53M$ 373.10K$ 538.90K$ 125.00K
Currency in USD

Bionoid Pharma Earnings and Revenue History

Bionoid Pharma Debt to Assets

Bionoid Pharma Cash Flow

Bionoid Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis